All participants in the prescription drug supply chain deserve scrutiny, but weakening the mechanisms that extract price concessions will not lower drug spending. The more likely outcomes are gains for drug companies and less efficient pharmacies, and higher drug costs. Effects will be especially felt by seniors on Medicare and by smaller employers that lack the leverage to offset the law’s new constraints.
The regulation is barely keeping up with the use
，推荐阅读咪咕体育直播在线免费看获取更多信息
No changes to the Python grammar are being proposed, only，推荐阅读爱思助手下载最新版本获取更多信息
04:27, 28 февраля 2026Мир